Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Neuroblastoma origin and therapeutic targets for immunotherapy
IV Kholodenko, DV Kalinovsky… - Journal of …, 2018 - Wiley Online Library
Neuroblastoma is a pediatric solid cancer of heterogeneous clinical behavior. The unique
features of this type of cancer frequently hamper the process of determining clinical …
features of this type of cancer frequently hamper the process of determining clinical …
Ovarian cancer stem cells and targeted therapy
Background Ovarian cancer has the highest ratio of mortality among gynecologic
malignancies. Chemotherapy is one of the most common treatment options for ovarian …
malignancies. Chemotherapy is one of the most common treatment options for ovarian …
[HTML][HTML] Tumoral heterogeneity in neuroblastoma
Neuroblastoma is a solid, neuroendocrine tumor with divergent clinical behavior ranging
from asymptomatic to fatal. The diverse clinical presentations of neuroblastoma are directly …
from asymptomatic to fatal. The diverse clinical presentations of neuroblastoma are directly …
Cancer stem cells in neuroblastoma: expanding the therapeutic frontier
Neuroblastoma (NB) is the most common extracranial solid tumor often diagnosed in
childhood. Despite intense efforts to develop a successful treatment, current available …
childhood. Despite intense efforts to develop a successful treatment, current available …
Strategies for isolating and enriching cancer stem cells: well begun is half done
J Duan, W Qiu, S Xu, B Wang, X Ye, Y **… - Stem cells and …, 2013 - liebertpub.com
Cancer stem cells (CSCs) constitute a subpopulation of cancer cells that have the potential
for self-renewal, multipotent differentiation, and tumorigenicity. Studies on CSC biology and …
for self-renewal, multipotent differentiation, and tumorigenicity. Studies on CSC biology and …
[HTML][HTML] Ovarian cancer and cancer stem cells—cellular and molecular characteristics, signaling pathways, and usefulness as a diagnostic tool in medicine and …
Simple Summary Ovarian cancer is still a high-risk, metastatic disease, often diagnosed at a
late stage. Difficulties in its treatment are associated with high resistance to chemotherapy …
late stage. Difficulties in its treatment are associated with high resistance to chemotherapy …
ALDH1 in combination with CD44 as putative cancer stem cell markers are correlated with poor prognosis in urothelial carcinoma of the urinary bladder
H Keymoosi, E Gheytanchi, M Asgari… - Asian Pacific Journal …, 2014 - koreascience.kr
Background: The aldehyde dehydrogenase 1 family member A1 (ALDH1A1) is one of the
promising markers for identifying cancer stem cells in many cancer types, along with other …
promising markers for identifying cancer stem cells in many cancer types, along with other …
The dual HDAC and PI3K inhibitor, CUDC-907, inhibits tumor growth and stem-like properties by suppressing PTX3 in neuroblastoma
M Li, Y Hu, J Wang, Y Xu, Y Hong… - International …, 2023 - spandidos-publications.com
Neuroblastoma (NB) is one of the common solid tumors in childhood and poses a threat to
the lives of children. Patients with advanced-stage or recurrent NB have a poor prognosis …
the lives of children. Patients with advanced-stage or recurrent NB have a poor prognosis …
Co-expression of putative cancer stem cell markers CD44 and CD133 in prostate carcinomas
Cancer stem cells (CSCs) are the main players of prostate tumorigenesis thus;
characterization of CSCs can pave the way for understanding the early detection, drug …
characterization of CSCs can pave the way for understanding the early detection, drug …
Reactive oxygen species from non-thermal gas plasma (CAP): implication for targeting cancer stem cells
Cancer remains a major global health challenge, with the persistence of cancer stem cells
(CSCs) contributing to treatment resistance and relapse. Despite advancements in cancer …
(CSCs) contributing to treatment resistance and relapse. Despite advancements in cancer …